MUMBAI: Shares of Divi's Laboratories rose a little over 4% after the company announced 29.3% year-on-year rise in its consolidated net profit to Rs502.02 crore for the quarter ended March. At 12pm, shares of the company traded at Rs4169.10 apiece, up 1.28% from previous close. The company reported a forex gain of Rs3 crore during the quarter under review. During FY21, the company took up another capex programme at an estimated investment of Rs400 crore, for fast-tracking a customs synthesis project. "Q4 topline was in line with I-direct estimates whereas profitability was higher than expected amid better gross margin performance.

Source: Mint May 31, 2021 07:16 UTC